Persistent URL of this record https://hdl.handle.net/1887/100389
In Collections
This item can be found in the following collections:
![The First, Multicenter, Double-Blind, Randomized, Parallel-Group Study of Certolizumab Pegol in Early Rheumatoid Arthritis Demonstrates Inhibition of Joint Damage Progression](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
The First, Multicenter, Double-Blind, Randomized, Parallel-Group Study of Certolizumab Pegol in Early Rheumatoid Arthritis Demonstrates Inhibition of Joint Damage Progression
- All authors
- Atsumi, T.; Yamamoto, K.; Takeuchi, T.; Yamanaka, H.; Ishiguro, N.; Tanaka, Y.; Eguchi, K.; Watanabe, A.; Origasa, H.; Shoji, T.; Togo, O.; Okada, T.; Heijde, D.M. van der; Miyasaka, N.; Koike, T.
- Date
- 2014-10-31
- Journal
- Arthritis and Rheumatology
- Volume
- 66
- Pages
- S1078 - S1079